跳至主要内容
临床试验/JPRN-UMIN000003089
JPRN-UMIN000003089已完成未知

Effects of beraprost sodium on improvement of insulin resistance in patients with type 2 diabetes and peripheral arterial disease - Effects of beraprost sodium on improvement of insulin resistance in patients with type 2 diabetes and peripheral arterial disease

Graduate School of Medicine, University of Tokyo Department of Metabolic Diseases0 个研究点目标入组 20 人开始时间: 2010年1月25日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 80years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • - Patients with bleeding tendancy - Patients with severe renal dysfunction - Patients with liver dysfunction - Patients with a past hystory of drug hypersensitivity - Pregnant women or women with breast-feeding - Patients who took prostaglandin derivatives within 3 months

研究者

发起方
Graduate School of Medicine, University of Tokyo Department of Metabolic Diseases

相似试验

Effects of beraprost sodium on improvement of... | 临床试验